Pharmaceuticals News and Research

RSS

New electrochemical method can remove extremely low levels of pollutants from water

When it comes to removing very dilute concentrations of pollutants from water, existing separation methods tend to be energy- and chemical-intensive. Now, a new method developed at MIT could provide a selective alternative for removing even extremely low levels of unwanted compounds.

10 May 2017

Swiss researchers discover potential way to design new antibiotics

Two Swiss research teams from the University of Bern and the ETH Zurich have developed a new method to shed light onto a mostly unknown process of bacterial protein production. Their results could be used for the design of new antibiotics.

10 May 2017

UT Southwestern study sheds light on role of hormone ghrelin in blood glucose control

UT Southwestern research investigating the blood glucose-regulatory actions of the hormone ghrelin may have implications for development of new treatments for diabetes.

10 May 2017

Three TSRI scientists receive awards from Royal Society of Chemistry

Three chemists from The Scripps Research Institute- Dale Boger, Jin-Quan Yu and Phil Baran- have received awards from the Royal Society of Chemistry, a renowned professional organization for chemists based in the United Kingdom, with more than 54,000 members worldwide.

10 May 2017

Blavatnik fund to accelerate research in life sciences

Inspired by the long tradition of innovation at Yale University, particularly in the life sciences, The Blavatnik Family Foundation has donated $10 million to Yale University to promote and to accelerate the development, application, and commercialization of breakthrough research in the life sciences.

9 May 2017

BGRF scientists help develop AI to expedite drug development for age-related conditions

The Chief Science Officer of the Biogerontology Research Foundation will present new research on artificial intelligence for drug discovery at the NVIDIA Graphics Technology Conference at the San Jose Convention Center, on Wednesday, May 10, 1:00 PM - 1:50 PM alongside two AI scientists from the BGRF and Insilico Medicine, where they will deliver a presentation titled "Applications of Generative Adversarial Networks to Drug Discovery in Oncology and Infectious Diseases".

9 May 2017

Study: Ovarian hormone changes may trigger headache in adolescent girls with migraine

Changes in female hormones may trigger headaches in adolescent girls, but their effect may depend on age and their stage of pubertal development, according to a new study from researchers at University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center.

8 May 2017

WHO to launch pilot project for prequalifying biosimilar cancer medicines

This year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in low- and middle-income countries.

8 May 2017

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

Although pain, memory and nicotine addiction may not seem to be related, they actually share a common player: the nicotinic acetylcholine receptors.

5 May 2017

Experts find benefits of antipsychotic medications to be much greater than side effects

An international group of experts has concluded that, for patients with schizophrenia and related psychotic disorders, antipsychotic medications do not have negative long-term effects on patients' outcomes or the brain.

5 May 2017

Advancing safety in healthcare products

True benefit from healthcare products requires an unrelenting focus on patient- and consumer-centered safety, a principle that is at the heart of J&J’s Credo and is embodied in the mission of the Office of the Chief Medical Officer (OCMO).

From Johnson & Johnson 5 May 2017

Discovery of signaling pathway offers new functional framework for treating schizophrenia

Neuroscientists at Tufts University School of Medicine have discovered a new signaling pathway that directly connects two major receptors in the brain associated with learning and memory – the N-methyl-D-aspartate receptor (NMDAR) and the alpha 7 nicotinic acetylcholine receptor (a7nAChR) – which has significance for current efforts to develop drugs to treat schizophrenia.

4 May 2017

New drug mimics health effects of exercise, say researchers

Scientists have managed to mimic the health effects of exercise in mice, simply by using a pill, according to a study published in Cell Metabolism. The drug activated a genetic pathway that is triggered by running, which led mice to burn off more fat and increase their stamina levels, despite them being sedentary.

4 May 2017

Synthetic biologists re-engineer yeast cells to manufacture antibiotic penicillin

The synthetic biologists from Imperial College London have re-engineered yeast cells to manufacture the nonribosomal peptide antibiotic penicillin. In laboratory experiments, they were able to demonstrate that this yeast had antibacterial properties against streptococcus bacteria.

4 May 2017

Study provides evidence for antidepressant effects of ketamine

Better known as an anesthetic or as an illicit hallucinogenic drug, ketamine has also long been noted for alleviating depression. But ketamine has not been tested in a large clinical trial, and all evidence of its antidepressant effects has come from anecdotes and small studies of fewer than 100 patients.

3 May 2017

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Researchers have discovered that a new anti-rejection drug that is gentler on the kidneys after liver transplant also reduces weight gain, which is common after surgery and can lead to serious complications for transplant patients.

3 May 2017

Scientists discover new cause of dangerous cardiac instabilities

Sudden cardiac death resulting from fibrillation – erratic heartbeat due to electrical instability – is one of the leading causes of death in the United States.

3 May 2017

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

The Biologics Prescribers Collaborative (BPC), a project of the Alliance for Patient Access, released a new white paper, “The State of Biosimilars Policy.” The paper is released in conjunction with a congressional briefing on Capitol Hill where experts will discuss the current biosimilars policy framework and its impact on prescribing, reimbursement and use.

3 May 2017

Pharma supply chain "needs to get out of its silos"

This was the message from Alan Kennedy of TEAM-UP speaking at the 2017 LogiPharma Conference in Montreux on April 25th - 27th 2017. Kennedy said that the pharma supply chain needs to prioritise getting out of its silos and start working in unison to push and embrace fundamental structural reform.

3 May 2017

NIST chemists publish new data on important compound’s thermodynamic properties

Amantadine hydrochloride may be the most common medication you've never heard of. This compound has been around for decades as the basis for antiviral and other medications, from flu therapy to treatments for brain disorders such as Parkinson's disease and the fatigue associated with multiple sclerosis.

2 May 2017

Pharmaceuticals News and Research

New electrochemical method can remove extremely low levels of pollutants from water

Swiss researchers discover potential way to design new antibiotics

UT Southwestern study sheds light on role of hormone ghrelin in blood glucose control

Three TSRI scientists receive awards from Royal Society of Chemistry

Blavatnik fund to accelerate research in life sciences

BGRF scientists help develop AI to expedite drug development for age-related conditions

Study: Ovarian hormone changes may trigger headache in adolescent girls with migraine

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Texas A&M researchers aim to develop one drug that treats pain, memory and nicotine addiction

Experts find benefits of antipsychotic medications to be much greater than side effects

Advancing safety in healthcare products

Discovery of signaling pathway offers new functional framework for treating schizophrenia

New drug mimics health effects of exercise, say researchers

Synthetic biologists re-engineer yeast cells to manufacture antibiotic penicillin

Study provides evidence for antidepressant effects of ketamine

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Scientists discover new cause of dangerous cardiac instabilities

Biologics prescribers collaborative releases new white paper: The State of Biosimilars Policy

Pharma supply chain "needs to get out of its silos"

NIST chemists publish new data on important compound’s thermodynamic properties

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring